Vertex

J&J Open to Expanding Hepatitis C Collaboration With Vertex
Bloomberg
Fri, 04/20/12 - 10:35 am
hepatitis C
JNJ
Vertex
Vertex: Watch New Hepatitis C Drug
Seeking Alpha
Wed, 04/11/12 - 11:46 am
hepatitis C
Vertex
Incivek
Abbott Laboratories
Bristol-Myers Squibb
Gilead
3 Strong Biotech Stocks Better Than Keryx
Seeking Alpha
Fri, 04/6/12 - 11:13 am
Keryx
Vertex
Achillion
Dendreon
How Much Further Can Rare Diseases Carry BioMarin?
Seeking Alpha
Thu, 03/29/12 - 05:19 pm
Biomarin
Amicus Therapeutics
Sanofi
Vertex
EASL Gives Wall Street's Privileged Investors Sneaky Preview to Key Hep C Data
TheStreet.com
Tue, 03/20/12 - 11:47 am
hepatitis C
EASL
Gilead
Bristol-Myers Squibb
Abbott Laboratories
Vertex
Merck
Recent FDA Approval Makes Vertex A Ripe Target For Takeover
Seeking Alpha
Thu, 03/1/12 - 12:45 pm
FDA
Vertex
M&A
Kalydeco
cystic fibrosis
Don't Count Vertex Out Just Yet
Motley Fool
Wed, 02/29/12 - 10:09 am
Vertex
Incivek
hepatitis C
Merck
Roche
Hepatitis C Remains A Hot Play
Seeking Alpha
Mon, 02/27/12 - 12:01 pm
hepatitis C
Bristol-Myers Squibb
Novartis
Gilead
Inhibitex
Merck
Vertex
Pharmasset
Enanta
Vertex: The Best Of The Companies Investing In Cystic Fibrosis
Seeking Alpha
Tue, 02/21/12 - 10:39 am
cystic fibrosis
Vertex
Gilead
Novartis
Sanofi
Friday's Overreaction Provides Great Entry Point For Gilead
Seeking Alpha
Tue, 02/21/12 - 09:01 am
Gilead
Vertex
hepatitis C
Pharmasset
PSI-7977
Achillion, Vertex rally on Gilead's woes
Marketwatch
Fri, 02/17/12 - 01:17 pm
Vertex
Gilead
Achillion
GS-7977
protease inhibitors
hepatitis C
Gilead, Vertex and the Mystery of Missing Hep C Patients
TheStreet.com
Mon, 02/13/12 - 10:31 am
Vertex
hepatitis C
Gilead
Vertex Pharma reports 4th-quarter profit as sales of hepatitis C drug Incivek reach $456.8M
Yahoo/AP
Fri, 02/3/12 - 09:46 am
Vertex
hepatitis C
Incivek
earnings
Vertex Pharmaceuticals Inc. Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Mon, 01/30/12 - 10:57 am
Vertex
earnings
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race
Xconomy
Tue, 01/24/12 - 10:56 am
Allos
Vertex
hepatitis C
Telaprevir
Incivek
3 Lessons From the J.P. Morgan Health-Care Confab
Motley Fool
Mon, 01/16/12 - 10:43 am
SOMA
Regeneron
Vertex
Gilead
GSK
Biocryst
Dendreon
InterMune
Analyzing 5 Biotech Stocks And Their Takeover Potential
Seeking Alpha
Fri, 01/13/12 - 10:33 am
Abbott Laboratories
Achillion
Alexion
Bristol-Myers Squibb
Gilead
GSK
Human Genome Sciences
Indenix
Inhibitex
JNJ
Pfizer
Vertex
Pharmasset
Biotech Investors Buoyed By Signs Of Speedier Drug Launches
Seeking Alpha
Mon, 01/9/12 - 10:40 am
drug launches
Dendreon
Incyte
Human Genome Sciences
Regeneron
Seattle Genetics
Vertex
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Oncothyreon
Keryx
Vical
Aeterna Zentaris
Eli Lilly
JNJ
Elan
Celgene
Pfizer
Gilead
Pharmasset
Threshold Pharmaceuticals
Celldex
Amgen
BioVex
Aveo Pharmaceutical
Amylin
Alkermes
Vertex
Cell Therapeutics
Amarin
ONYX Pharmaceuticals
Vivus

Pages